. Author manuscript; available in PMC: 2015 Apr 1.

Published in final edited form as: Breast Cancer Res Treat. 2014 Mar 2;144(3):591–597. doi: 10.1007/s10549-014-2891-0

Table 4. Univariate predictors of 18-month CRA (n = 120).

Characteristic	No CRA (n = 19)	CRA (n = 81)	p value
AMH (median)	1.25 ng/mL	0.06 ng/mL	<0.0001
Age (median)	37 years	46 years	<0.0001
Race			1.00
White	16	69
Other	3	12
Treatment arm			0.36
No bevacizumab	6	17
Bevacizumab	13	64
Tamoxifen use			0.13
No	12	35
Yes	7	46

CRA chemotherapy-related amenorrhea, AMH anti-mullerian hormone